We are excited to share that Redesign Health team members and leaders from a number of our Operating Companies will attend HLTH in Las Vegas later this month. With a focus on health innovation, HLTH brings together stakeholders from the entire health ecosystem and provides a great opportunity to connect with leaders.
We are excited to share that Redesign Health team members and leaders from a number of our Operating Companies will attend HLTH in Las Vegas later this month. With a focus on health innovation, HLTH brings together stakeholders from the entire health ecosystem and provides a great opportunity to connect with leaders.
If you’re attending HLTH, don’t miss the opportunity to hear from our thought leaders. Be sure to add the following sessions to your schedule:
Doom or Boom? Digital Health’s Financial Future
November 15, 2022 at 11 AM PST on the Arena Stage.
When the good times are rolling, it’s easier to take risks in the short term. The funding is flowing, outlooks are rosy, what could go wrong, right? The real test of resilience is in a market downturn, which is where we find ourselves now. Has the digital health bubble finally burst? Let’s take a step back and evaluate the current state of the market, look at both short and long term predictions and dissect what the heck founders should be doing during this unsettling time. Layoffs and down rounds are not always the answer.
A seasoned healthcare operator with 30+ years in the digital health industry, Missy has worked at large technology companies (Amazon, Google, Box), startups, foundations, the U.S. government and venture capital. She was a founding member of the Alexa Health & Wellness team at Amazon, led Box’s healthcare & life sciences division during their IPO, and was the founding executive of Google Health. Missy worked under President George W. Bush in the U.S. Department of Health and Human Services (HHS), where she helped start the inaugural Office of the National Coordinator for Health Information Technology (ONC) which led to the HITECH Act. Missy also worked in venture capital at Morgenthaler Ventures, where she helped invest in several digital health companies: Doximity, Practice Fusion, Viewics, HealthLoop and Vida Health. She also worked at the Kaiser Family Foundation and Aetna. At Redesign Health, she sits on the boards for UpLift, Overalls and HealthQuarters.
The Vertical Re-imagination of Health & Wellness
November 14, 2022 at 11:00 AM PST on the Garden Stage
We’re moving towards a future where we’ll have a different app, membership, platform, etc. for each and every one of our health and wellness needs. Each is a trusted source of care, motivation and more importantly a strong sense of community with other people on a similar path to well-being. Each specialized company built squarely for the unique needs of the people they serve, never attempting to be a one-size fit all. Each member gets that personalized touch, earning their loyalty for the entirety of their health and wellness journey, not simply for a blip in time. The future of wellness is personalized and community-oriented. Meet leaders on the forefront of vertically re-imagined health.
Amy brings a distinguished record of enterprise leadership and business success in the beauty, fashion, and fitness industry to her CEO role at Ever/Body, a personalized aesthetic dermatology company that combines medical-grade services with a high-tech, digitally-connected patient experience. Under Amy’s leadership, Ever/Body grew the business by 257% YOY, and launched a first-of-its-kind enhanced education program to support the brand’s mission of supporting each client on their personal beauty journey.
Amy is a bold visionary, nimble strategist, and inspiring organizational leader who has built businesses from the ground up. She’s known for her ability to revitalize brands and accelerate growth and profitability, whether for established companies or start-ups. Amy was named one of Entrepreneur Magazine’s 100 Powerful Women of 2020.
Prior to joining Ever/Body, Amy was the CEO of GLAMSQUAD, a technology-powered, consumer-focused company that provides on-demand, at-home beauty services. At GLAMSQUAD, she rapidly scaled the business, opened new markets, launched proprietary technology, forged strategic partnerships and launched branded products.
Prior to GLAMSQUAD, Amy was the CEO of CorePower Yoga, President of C. Wonder, and held several senior executive roles at Cole Haan, DKNY and Tory Burch. Amy began her career at Bloomingdale’s. Amy received a Bachelor of Science degree in Fashion Marketing from the University of Massachusetts at Amherst.
Medication vs. Diet: Is an Apple a Day Enough?
November 14, 2022 at 11:50 AM PST on the Garden Stage
Food is fuel. In many cases, food is the first line of defense against obesity, type II diabetes, heart disease, kidney disease, liver disease, and the list goes on and on. But like everything healthy, it’s not that simple. Personal nutrition is a complex puzzle and when that M&M;’s container is readily accessible, we might abandon the parameters of a diet. We’re only human, right? Cardio metabolic health is a cornerstone of wellness, but at what point do genetics overpower environmental effects? Novel medications have proven outcomes in healthy weight-loss and improved metabolism, but it would be remiss to not mention the adverse side-effects. Hear from leaders on both sides of the debate, ready to masterfully defend their model.
Isabelle Kenyon is the Founder & CEO of Calibrate, a metabolic health company on a mission to change the way the world treats weight. In two years, Calibrate has raised more than $125 million from leading investors, including Founders Fund, Tiger Global, Optum Ventures, Forerunner Ventures, Threshold Ventures, and Redesign Health, and has published clinically-reviewed results from its One-Year Metabolic Reset that exceeded the best outcomes from clinical trials across all metabolic markers. Calibrate was recognized as a World Economic Forum Technology Pioneer in 2021 and by Fast Company’s World Changing Ideas in 2022.
Prior to Calibrate, Isabelle led business operations, growth, and strategic partnerships & communications at Capsule, a technology business rebuilding the pharmacy from the inside out. Before Capsule, she worked at beloved consumer brands in London and New York. Isabelle began her career as an investment banker in Hong Kong and graduated from the University of Pennsylvania. She was selected to the Forbes 30 Under 30 list in 2015.
Care that Gives a Homey Feeling
November 16, 2022 at 10:20 AM PST on the Seaport Stage
The global pandemic forced us all to look inward and stay in. Our homes kept us safe, comfortable, and calm throughout a trying several years. This shift added to the viability of alternative methods of healthcare delivery and physical sites of care. By reconsidering how we deliver care, namely the superior efficacy of care in the home, we are on the cusp of transforming the unsustainable $4 trillion cost of medicine in our country while addressing our nation’s overall health and well-being. But what happens when a home is less than equipped to accept this care? Further, how can we scale home-based care while proactively preventing additional disparity? Join top home health leaders to dive into the pros and cons of this seismic shift in health.
Redesign Health Panelist:
Inna Plumb
COO & Co-Founder, MedArrive
Inna was a founding partner at Redesign Health, where she helped to build a variety of healthcare companies including Calibrate and Vault, while also leading the Venture Building team. She has a strong background in Operations and Finance, having led the Supply Chain team at Blue Apron and starting her career as a banker at Evercore Partners and subsequently an investor at Soros Fund Management.
Leaders from additional Redesign Health Operating Companies will also be attending HLTH, including Springtide, Together Senior Health, TempoPay, Jasper, Keen, and DUOS.
We’d love to see you there! Feel free to reach out to members of the Redesign Health team through the HLTH portal.
.webp)